SARAH RAYMOND: Open Payments
NPI 1164024931 · HAVERHILL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 15 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $193 |
| Regeneron Healthcare Solutions, Inc. | 1 | $109 |
| Janssen Biotech, Inc. | 3 | $59 |
| CapsoVision, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Ardelyx, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
Products named: REZDIFFRA, TREMFYA, CapsoCam Plus, XIFAXAN, IBSRELA, Wegovy, VELSIPITY, VOQUEZNA.
Industry payments across MA — which companies pay providers there.
